Chilean oral implants research & development claims inroads with Trinon Titanium:
This article was originally published in Clinica
Executive Summary
A strategic alliance between a leading Chilean oral implantation centre and Trinon Titanium, a German R&D specialist in this area, has resulted in the development of a "low-cost, simplified design of oral implants". So said Dr Jorge Jofre, director of the Centro de Rehabilitacion Oral Avanzada e Implantologia (CRAI), based at the Chilean university of Concepcion, of plans to mass produce the implant and market it in Chile, Europe and Asia. The CRAI says that such plans have been enabled by an international collaboration that extends beyond its alliance with Karlsruhe-based Trinon, now involving the universities of Gothenburg (Sweden), Hiroshima (Japan), UCLA (US) and Illinois (US).
You may also be interested in...
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.
Lilly Can Rest Easy As Tirzepatide Scores Phase III Sleep Apnea Win
Topline results from two studies in obstructive sleep apnea among obese adults showed efficacy crossing the 50% threshold that physicians have called clinically meaningful.